期刊文献+

针对gyrA基因突变的反向斑点杂交技术快速检测结核分枝杆菌喹诺酮耐药性的研究 被引量:2

Reverse dot blot hybridization of gyrA mutation for rapid detection of Mycobacterium tuberculosis resistance to quinolone
原文传递
导出
摘要 目的建立快速检测结核分枝杆菌喹诺酮耐药性的反向斑点杂交(reverse dot blot hybridization,RDBH)技术,并观察其效果。方法针对结核分枝杆菌gyr A基因序列及常见的突变位点,分别设计1条野生型和7条突变型探针,建立RDBH技术,对临床分离结核分枝杆菌菌株进行喹诺酮耐药性检测,以比例法药敏试验和DNA测序做对照。结果应用比例法药敏试验、DNA测序、RDBH三种方法分别检测59株喹诺酮耐药株和51株喹诺酮敏感株,与比例法相比,RDBH试验灵敏度和特异度分别为69.49%(41/59)、100%(51/51),符合度为83.63%;而RDBH与DNA测序结果比较,敏感度和特异度分别为97.56%(40/41),98.55%(68/69),符合度达98.18%。结论RDBH技术检测结核分枝杆菌喹诺酮耐药具有良好的灵敏度、特异度和符合度。 Objective To establish a reverse dot blot hybridization (RDBH) assay for the rapid detection of Mycobacterium tuberculosis resistance to quinolone. Methods Based on the sequence results of gyrA gene and common mutation sites in M. tuberculosis, one wildtype and seven mutant oligonucleotide probes were designed. Meanwhile, conventional drug susceptibility test (DST) and DNA sequencing were performed to evaluate the effect of RDBH assay. Results A total of 59 quinolone resistant M. tuberculosis isolates and 51 quinolone sensitive M. tuberculosis isolates were detected by using DST, DNA sequencing and RDBH assay. Compared with DST results, the sensitivity and specificity of RDBH assay were 69. 49% (41/59) and 100% (51/51). Compared with DNA sequencing, the sensitivity, specificity and conformity of RDBH were 97. 56% (40/41), 98.55% (68/69) and 98.18% ,respectively. Conclusion RDBH is a rapid, simple and efficient assay to detect quinolone resistant M. tuberculosis.
出处 《疾病监测》 CAS 2015年第3期218-222,共5页 Disease Surveillance
基金 国家科技重大专项(No.2013ZX10003002-001)~~
关键词 结核分枝杆菌 喹诺酮 耐药 反向斑点杂交 Mycobacterium tuberculosis Quinolones Drug resistance Reverse Dot Blot Hybridization
  • 相关文献

参考文献23

  • 1WHO. Global tuberculosis report 2013[R]. Geneva: World Health Organization,2013.
  • 2Zhao YL, Xu SF, Wang LX, et al. National survey of drug-resistant tuberculosis in China[J]. N Engl J Med,2012,366(23):2161-2170.
  • 3Suresh N, Singh UB, Arora J, et al. Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by in-house, reverse line blot assay[J]. Diagn Microbiol Infect Dis,2006,56(2):133-140.
  • 4Huang T-S, Kunin CM, Shin-Jung Lee S, et al. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwan Residents medical centre: 1995-2003[J]. J Antimicrob Chemother,2005,56(6):1058-1062.
  • 5Takiff HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations[J]. Antimicrob Agents Chemother,1994, 38(4):773-780.
  • 6Mokrousov I, Otten T, Manicheva O, et al. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia[J]. Antimicrob Agents Chemother,2008,52(8):2937-2939.
  • 7Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance[J]. Bull World Health Organ,1963, 29(5):565-578.
  • 8Yu Q, Su YK, Lu B, et al. Genetic diversity of Mycobacterium tuberculosis isolates from Inner Mongolia, China[J]. PLoS One,2013,8(5):e57660.
  • 9Yin XM, Yu ZX. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong province in China[J]. J Infect,2010,61(2):150-154.
  • 10Salah Eldin A, Mostafa NM, Mostafa SI. Detection of fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates as determined by gyrA/B gene mutation by using PCR technique[J]. Egyptian J Chest Dis Tubercul,2012,61(4):349-353.

同被引文献20

  • 1World Health Organization. Global tuberculosis report 2015. Geneva~ World Health Organization, 2015.
  • 2Nosova EY, Bukatina AA, Isaeva YI), et a[. Analysis of mu- tations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin. J Med Microbiol, 2013, 62 (Pt 1)~ 108 113.
  • 3Shi R, Zhang J, Li C, et al. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as de- termined by gy~4 mutation analysis using denaturing high- pressure liquid chromatography and I)NA sequencing. J Clin Microbiol, 2006, 44(12) : 4566-4568.
  • 4Sullivan EA, Kreiswirth BN, Palumbo L, et al. Emergence of fluoroquinolone resistant tuberculosis in New York City. Lan- cet, 1995,345 (8958) : 1148-1150.
  • 5Mokrousov I, Otten T, Manicheva O, et al. Molecular charac- terization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother, 2008, 52 (8) .2937-2939.
  • 6Zhu C, Zhang Y, Shen Y, et al. Molecular characterization of fluoroquinolone resistant Mycobacterium tuberculosis clinical iso- lates from Shanghai, China. Diagn Microbiol Infect Dis,2012, 73(3) : 260-263.
  • 7Huang TS, Kunin CM, Shin-Jung Lee S, et al. Trends in flu- oroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwan Residents medical centre: 1995-2003. J Antimicrob Che- mother, 2005,56(6) : 1058 1062.
  • 8逄宇,夏辉,姜广路,刘冠,梁倩,周杨,王胜芬,尚媛媛,赵冰,宋媛媛,赵雁林.中国结核分枝杆菌寡核苷酸基因分型及其耐药性分析[J].中华检验医学杂志,2011,34(11):1023-1028. 被引量:24
  • 9范齐文,郭建,张慧涨,吴晓渊,胡香南,钱雪琴,邓桂林,康涵,吴文娟.M/XDR-TB的快速分子检测和耐药特征分析[J].中华微生物学和免疫学杂志,2011,31(12):1133-1137. 被引量:11
  • 10逄宇,李桂莲,王玉峰,宋媛媛,李强,欧喜超,董海燕,赵雁林.单耐利福平结核分枝杆菌耐药分子机制研究[J].中国防痨杂志,2012,34(5):275-279. 被引量:6

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部